Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Biochemical diagnoses inborn errors of mitochondrial fatty acid
oxidation, including deficiencies of medium-chain acyl-Co-A
dehydrogenase, long-chain 3-hydroxyacyl-Co-A dehydrogenase,
very long-chain acyl-Co-A dehydrogenase, and glutaricacidemia
type 2.
This test diagnoses inborn errors of mitochondrial fatty acid oxidation
(FAO) in patients who are unable to derive energy from fat stores and are
dependent on glucose for energy. Patients affected with FAO disorders
are at risk of sudden unexpected death, usually triggered by
hypoglycemia, accumulation of toxic metabolites, and organ failure in
response to fasting or intercurrent illnesses. This test is particularly
effective in the work-up of clinically asymptomatic patients (i.e., not
experiencing an acute episode).
Octanoic Acid, C8:0
<1 year: 7-63 umol/L
1-17 years: 9-41 umol/L
> or =18 years: 8-47 umol/L
Decenoic Acid, C10:1
<1 year: 0.8-4.8 umol/L
1 -17 years: 1.6-6.6 umol/L
> or =18 years: 1.8-5.0 umol/L
Decanoic Acid, C10:0
<1 year: 2-62 umol/L
1 -17 years: 3-25 umol/L
> or =18 years: 2-18 umol/L
Lauroleic Acid, C12:1
<1 year: 0.6-4.8 umol/L
1 -17 years: 1.3-5.8 umol/L
> or =18 years: 1.4-6.6 umol/L
Lauric Acid, C12:0
<1 year: 6-190 umol/L
1 -17 years: 5-80 umol/L
> or =18 years: 6-90 umol/L
Tetradecadienoic Acid, C14:2
<1 year: 0.3-6.5 umol/L
1 -17 years: 0.2-5.8 umol/L
> or =18 years: 0.8-5.0 umol/L
Myristoleic Acid, C14:1
<1 year: 1-46 umol/L
1 -17 years : 1-31 umol/L
> or =18 years: 3-64 umol/L
Myristic Acid, C14:0
<1 year: 30-320 umol/L
1 -17 years: 40-290 umol/L
> or =18 years: 30-450 umol/L
Hexadecadienoic Acid, C16:2
<1 year: 4-27 umol/L
1 -17 years: 3-29 umol/L
> or =18 years: 10-48 umol/L
Palmitoleic Acid, C16:1w7
<1 year: 20-1,020 umol/L
1 -17 years: 100-670 umol/L
> or =18 years: 110-1,130 umol/L
Palmitic Acid, C16:0
<1 year: 720-3,120 umol/L
1 -17 years: 960-3,460 umol/L
> or =18 years: 1,480-3,730 umol/L
Linoleic Acid, C18:2w6
1-31 days: 350-2,660 umol/L
32 days-11 months: 1,000-3,300 umol/L
1 -17 years: 1,600-3,500 umol/L
> or =18 years: 2,270-3,850 umol/L
Oleic Acid, C18:1w9
<1 year: 250-3,500 umol/L
1 -17 years: 350-3,500 umol/L
> or =18 years: 650-3,500 umol/L
Stearic Acid, C18:0
<1 year: 270-1,140 umol/L
1 -17 years: 280-1,170 umol/L
> or =18 years: 590-1,170 umol/L
FAO disorders are recognized on the basis of disease-specific
metabolite patterns that are correlated to the results of other
investigations in plasma (carnitine, acylcarnitines) and urine
(organic acids, acylglycines).
For nutritional assessment, a 12-14 hour fast is required; however,
patients suspected of having a FAO disorder should not
fast before testing owing to the possibility of acute metabolic
decompensation. Instead, draw the specimen at the longest fast
possible, just before feeding.
1. Stellaard F, ten Brink HJ, Kok RM et al: Stable isotope dilution analysis
of very long chain fatty acids in plasma, urine, and amniotic fluid by
electron capture negative ion mass fragmentography.
Clin Chim Acta 1990;192:133-144
2. ten Brink HJ, Stellaard F, van den Heuvel CM et al: Pristanic acid
and phytanic acid in plasma from patients with peroxisomal disorders:
stable isotope dilution analysis with electron capture negative mass
fragmentography. J of Lipid Res 1992;33:41-47
3. Rinaldo P, Matern D, Bennett MJ: Fatty acid oxidation disorders.
Ann Rev Physiol 2002;64:477-502